Have you been eager to see how Humana Inc (HUM) performed in Q4 in comparison with the market expectations? Let’s quickly scan through the key facts from this popular global professional services company’s earnings release this morning.
An Earnings Beat
Humana came out with operating earnings of $2.06 per share, which beat theZacks Consensus Estimate of $2.00.
Humana Inc. Price, Consensus and EPS Surprise
Earnings Surprise History
Humana has a decent earnings surprise history. The company delivered positive surprises in each of the last four quarters, with an average beat of 6.9%.
Revenues Beat Expectations
Humana posted adjusted consolidated revenues of $13,189 million, which was higher than the Zacks Consensus Estimate of $13,023 million.
Key Q4 Statistics
Benefit ratio deteriorated 200 basis points to 83% in the quarter.
Operating cost ratio improved 100 basis points to 13.9%.
Operating cash flow totaled $2.8 billion, up 89% over the prior year quarter.
2018 Guidance
For 2018, Humanaexpects adjusted earnings per diluted share to be in the range of $13.50- $14.00.
Total revenues are expected to be in the range of $55.8 billion to $56.4 billion.
What Zacks Rank Says
Centenesports a Zacks Rank #3 (Hold). However, since the latest earnings performance yet to be reflected in the estimate revisions, the rank is subject to change. While things apparently look favorable, it all depends on what sense the just-released report makes to the analysts.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this Humana earnings report!
Zacks Top 10 Stocks for 2018In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?
Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp. and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2018 today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Have you been eager to see how Humana Inc (HUM) performed in Q4 in comparison with the market expectations? Let’s quickly scan through the key facts from this popular global professional services company’s earnings release this morning.
An Earnings Beat
Humana came out with operating earnings of $2.06 per share, which beat theZacks Consensus Estimate of $2.00.
Humana Inc. Price, Consensus and EPS Surprise
Earnings Surprise History
Humana has a decent earnings surprise history. The company delivered positive surprises in each of the last four quarters, with an average beat of 6.9%.
Revenues Beat Expectations
Humana posted adjusted consolidated revenues of $13,189 million, which was higher than the Zacks Consensus Estimate of $13,023 million.
Key Q4 Statistics
Benefit ratio deteriorated 200 basis points to 83% in the quarter.
Operating cost ratio improved 100 basis points to 13.9%.
Operating cash flow totaled $2.8 billion, up 89% over the prior year quarter.
2018 Guidance
For 2018, Humanaexpects adjusted earnings per diluted share to be in the range of $13.50- $14.00.
Total revenues are expected to be in the range of $55.8 billion to $56.4 billion.
What Zacks Rank Says
Centenesports a Zacks Rank #3 (Hold). However, since the latest earnings performance yet to be reflected in the estimate revisions, the rank is subject to change. While things apparently look favorable, it all depends on what sense the just-released report makes to the analysts.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this Humana earnings report!
Zacks Top 10 Stocks for 2018In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?
Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp. and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2018 today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on HUM - FREE